Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

References for PMC Articles for PubMed (Select 22643827)

1.

Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.

Phillips JJ, Huillard E, Robinson AE, Ward A, Lum DH, Polley MY, Rosen SD, Rowitch DH, Werb Z.

J Clin Invest. 2012 Mar;122(3):911-22. doi: 10.1172/JCI58215. Epub 2012 Feb 1.

2.

Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner.

Duarte CW, Willey CD, Zhi D, Cui X, Harris JJ, Vaughan LK, Mehta T, McCubrey RO, Khodarev NN, Weichselbaum RR, Gillespie GY.

PLoS One. 2012;7(1):e29653. doi: 10.1371/journal.pone.0029653. Epub 2012 Jan 5.

3.

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.

Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL, Kim SH, Turski A, Azodi Y, Yang Y, Doucette T, Colman H, Sulman EP, Lang FF, Rao G, Copray S, Vaillant BD, Aldape KD.

Genes Dev. 2011 Dec 15;25(24):2594-609. doi: 10.1101/gad.176800.111.

4.

Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

Snuderl M, Fazlollahi L, Le LP, Nitta M, Zhelyazkova BH, Davidson CJ, Akhavanfard S, Cahill DP, Aldape KD, Betensky RA, Louis DN, Iafrate AJ.

Cancer Cell. 2011 Dec 13;20(6):810-7. doi: 10.1016/j.ccr.2011.11.005. Epub 2011 Dec 1.

5.

Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148.

Whiteford JR, Xian X, Chaussade C, Vanhaesebroeck B, Nourshargh S, Couchman JR.

Mol Biol Cell. 2011 Oct;22(19):3609-24. doi: 10.1091/mbc.E11-02-0099. Epub 2011 Aug 3.

6.

M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis.

Zhou H, Roy S, Cochran E, Zouaoui R, Chu CL, Duffner J, Zhao G, Smith S, Galcheva-Gargova Z, Karlgren J, Dussault N, Kwan RY, Moy E, Barnes M, Long A, Honan C, Qi YW, Shriver Z, Ganguly T, Schultes B, Venkataraman G, Kishimoto TK.

PLoS One. 2011;6(6):e21106. doi: 10.1371/journal.pone.0021106. Epub 2011 Jun 16.

7.

Heparan sulfate proteoglycans.

Sarrazin S, Lamanna WC, Esko JD.

Cold Spring Harb Perspect Biol. 2011 Jul 1;3(7). pii: a004952. doi: 10.1101/cshperspect.a004952. Review.

8.

SULFs in human neoplasia: implication as progression and prognosis factors.

Bret C, Moreaux J, Schved JF, Hose D, Klein B.

J Transl Med. 2011 May 21;9:72. doi: 10.1186/1479-5876-9-72.

9.

Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial.

Hegi ME, Diserens AC, Bady P, Kamoshima Y, Kouwenhoven MC, Delorenzi M, Lambiv WL, Hamou MF, Matter MS, Koch A, Heppner FL, Yonekawa Y, Merlo A, Frei K, Mariani L, Hofer S.

Mol Cancer Ther. 2011 Jun;10(6):1102-12. doi: 10.1158/1535-7163.MCT-11-0048. Epub 2011 Apr 6.

10.

Heparanase Modulates Shh and Wnt3a Signaling in Human Medulloblastoma Cells.

Ridgway LD, Wetzel MD, Marchetti D.

Exp Ther Med. 2011 Mar 1;2(2):229-238.

11.

SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans.

Liu KW, Feng H, Bachoo R, Kazlauskas A, Smith EM, Symes K, Hamilton RL, Nagane M, Nishikawa R, Hu B, Cheng SY.

J Clin Invest. 2011 Mar;121(3):905-17. doi: 10.1172/JCI43690.

12.

PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models.

Dredge K, Hammond E, Handley P, Gonda TJ, Smith MT, Vincent C, Brandt R, Ferro V, Bytheway I.

Br J Cancer. 2011 Feb 15;104(4):635-42. doi: 10.1038/bjc.2011.11. Epub 2011 Feb 1.

13.

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.

Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM.

Clin Cancer Res. 2011 Mar 15;17(6):1603-15. doi: 10.1158/1078-0432.CCR-10-2563. Epub 2010 Dec 6.

14.

Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity.

Ramani VC, Yang Y, Ren Y, Nan L, Sanderson RD.

J Biol Chem. 2011 Feb 25;286(8):6490-9. doi: 10.1074/jbc.M110.183277. Epub 2010 Dec 3.

15.

PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.

Ozawa T, Brennan CW, Wang L, Squatrito M, Sasayama T, Nakada M, Huse JT, Pedraza A, Utsuki S, Yasui Y, Tandon A, Fomchenko EI, Oka H, Levine RL, Fujii K, Ladanyi M, Holland EC.

Genes Dev. 2010 Oct 1;24(19):2205-18. doi: 10.1101/gad.1972310.

16.

The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation.

Lai JP, Oseini AM, Moser CD, Yu C, Elsawa SF, Hu C, Nakamura I, Han T, Aderca I, Isomoto H, Garrity-Park MM, Shire AM, Li J, Sanderson SO, Adjei AA, Fernandez-Zapico ME, Roberts LR.

Hepatology. 2010 Nov;52(5):1680-9. doi: 10.1002/hep.23848.

17.

Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate.

Rosen SD, Lemjabbar-Alaoui H.

Expert Opin Ther Targets. 2010 Sep;14(9):935-49. doi: 10.1517/14728222.2010.504718. Review.

18.

Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance.

Fan QW, Weiss WA.

Curr Top Microbiol Immunol. 2010;347:279-96. doi: 10.1007/82_2010_67. Review.

19.

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.

Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, Grundy RG, Baker SJ.

J Clin Oncol. 2010 Jun 20;28(18):3061-8. doi: 10.1200/JCO.2009.26.7252. Epub 2010 May 17.

20.

A multigene predictor of outcome in glioblastoma.

Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, Popoff S, Nutt CL, Louis DN, Cairncross JG, Gilbert MR, Phillips HS, Mehta MP, Chakravarti A, Pelloski CE, Bhat K, Feuerstein BG, Jenkins RB, Aldape K.

Neuro Oncol. 2010 Jan;12(1):49-57. doi: 10.1093/neuonc/nop007. Epub 2009 Oct 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk